Denis Ullrich

Denis Ullrich specialises in advising on the sale and purchase of companies and shares in companies (M&A), the incorporation of companies and the reorganisation of companies and groups. His work also includes restructuring and crisis transactions. His clients include medium-sized companies, international groups and strategic investors from various branches as well as private equity companies and entrepreneurs within the framework of succession planning. Furthermore, Denis Ullrich advises shareholders, management board members, managing directors, supervisory boards and advisory councils on all matters pertaining to corporate law.

Corporate/M&A
Restructuring & Insolvency
Start-ups & Venture Capital

Denis Ullrich studied law majoring in economics at the University of Bayreuth (Germany). He joined Luther in 2005.

• The Legal 500 Germany 2024: Recommendation in "Industry Focus - Healthcare" (first recommendation in 2023, first mention in 2020, "Denis Ullrich is a very competent and committed colleague who was available to me as a professionally experienced dialogue partner in many matters from corporate law to pharmaceutical law and provided me with valuable support in my work. We were always able to develop economically sensible and goal-oriented solutions for our company in all joint projects.") and mention in "City Focus Leipzig" (first recommendation in 2023)
• The Legal 500 Germany 2019: Mention in the category "Restructuring and Insolvency - Restructuring"

• QSIL SE: advice on the acquisition of the EMEA activities of the H.C. Starck Group in Germany, England, China and India; advice on the acquisition of High Tech Ceran; advice on the acquisition of ROBU Glasfilter-Geräte GmbH and on the sale of H.C. Starck Special Materials (Taicang) Company Ltd.
• Lyomark Pharma GmbH: advice on the sale of the pharmaceutical contract manufacturer and developer (CDMO) Lyocontract GmbH to Great Point Partners (PE)
• Puraglobe Holding GmbH: advice on the joint venture for the construction of HyLube refineries and on various acquisitions in the waste disposal sector in Germany, the Netherlands and Poland, as well as on the acquisition of ITAP GmbH - Innovative Technologien und Anlagenplanung; advice on the sale of Baufeld Chemie GmbH and of the light oil separator division, both to Remondis
• Warburg Pincus (PE): advice on the acquisition of outpatient care structures in Germany (various hospital transactions and acquisitions of medical care centre groups)
• Labelprint 24 Group: advice on the sale of the group of companies to All4Labels Global Group/Triton
• IDT Biologika GmbH: advice on the carve-out and sale of the animal health division to Ceva Sante Animale
• Greiner Bio-One: advice on a joint venture for digital traceability of pre-analytics products
• Shareholder of i2s Intelligente Sensorsysteme Dresden GmbH: advice on the sale of the company to Amphenol Corporation
• Shareholder of Chainmaster Bühnentechnik GmbH: advice on the sale of the company to Liftket Hofmann GmbH/AFINUM
• Pharmaceutical group: advice on the acquisition of a production facility in Germany
• Pharmaceutical group: legal advice on the reorganisation of an investment
• Pharmaceutical group: advice on the sale of a business unit, including international pharmaceutical marketing authorisations
• Biotechnology company: advice on various M&A projects and development co-operations
• Mitteldeutsche Braunkohlengesellschaft mbH (MIBRAG): advice on corporate structuring of recultivation security for future surface mine reclamation

• 01.03.2013: Health-Claims-Verordnung – Das regulatorische Umfeld für die Lebensmittelwerbung nach Inkrafttreten der Art. 13 Liste
• 01.12.2012: Kreatives Werben mit Health Claims

• 24.02.2010: Rechte und Pflichten des Prokuristen, Fachverlag der Verlagsgruppe Handelsblatt GmbH, WSF Wirtschaftsseminare
• 12.08.2009: Rechte und Pflichten des Prokuristen, Fachverlag der Verlagsgruppe Handelsblatt GmbH, WSF Wirtschaftsseminare